68 studies found for:    Open Studies | "Pigmentation Disorders"
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting Maintenance Treatment of Non Segmental Vitiligo With Tacrolimus Ointment 0.1% Versus Control
Conditions: Pigmentation Disorders;   Vitiligo
Interventions: Drug: Protopic;   Drug: Placebo : Diprobase
2 Unknown  Use of Epidermal Expansion System for Epidermal Grafting on Hypopigmented Skin and Surgical Wounds
Conditions: Surgical Wound;   Hypo-pigmented Skin
Intervention: Device: Momelan Technologies Epidermal Graft Harvesting System
3 Recruiting Feasibility of Upright Bed Position in ARDS Patients
Conditions: Critical Illness;   Acute Respiratory Failure;   Adult Syndrome
Intervention: Other: Intervention Arm
4 Not yet recruiting Nevus Doctor Clinical Decision Support
Conditions: Nevus;   Melanoma
Intervention: Device: Nevus doctor program
5 Unknown  Can Intravenous Vitamin C Improve Skin Hyperpigmentation in Long-Term Hemodialysis Patients?
Condition: Kidney Failure, Chronic
Intervention: Drug: vitamin C, intravenous injection
6 Recruiting Midostaurin in Indolent Systemic Mastocytosis
Condition: Indolent Systemic Mastocytosis
Intervention: Drug: Midostaurin,
7 Recruiting Clinical, Cellular, and Molecular Investigation Into Oculocutaneous Albinism
Conditions: Albinism;   Oculocutaneous Albinism;   Foveal Hypoplasia;   Hypopigmentation;   Nystagmus
Intervention:
8 Recruiting Relevance of Imiquimod as Neo-adjuvant Treatment to Reduce Excision Size and the Risk of Intralesional Excision in Lentigo Malignant of the Face
Condition: Lentigo Maligna Melanoma (Head or Neck)
Interventions: Drug: Imiquimod cream + surgery;   Drug: vehicle + surgery
9 Recruiting Efficacy of Red Light in Vitiligo
Condition: Vitiligo
Intervention: Procedure: Red light
10 Recruiting Efficacy and Safety of Intralesional Corticosterois in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Drug: Triamcinolone Acetonide
11 Unknown  Prevalence of Carbohydrate Intolerance in Lean and Obese Children
Conditions: Obesity;   Glucose Intolerance;   Diabetes;   Acanthosis Nigricans
Intervention:
12 Recruiting Examination of Clinical and Laboratory Abnormalities in Patients With Defective DNA Repair: Xeroderma Pigmentosum, Cockayne Syndrome, or Trichothiodystrophy
Conditions: Cockayne Syndrome;   Skin Cancer;   Xeroderma Pigmentosum;   Trichothiodystrophy;   Genodermatosis
Intervention:
13 Recruiting A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies
Conditions: Adult Acute Lymphoblastic Leukemia in Remission;   Adult Acute Myeloid Leukemia in Remission;   Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities;   Adult Acute Myeloid Leukemia With Del(5q);   Adult Acute Myeloid Leukemia With Inv(16)(p13;q22);   Adult Acute Myeloid Leukemia With t(15;17)(q22;q12);   Adult Acute Myeloid Leukemia With t(16;16)(p13;q22);   Adult Acute Myeloid Leukemia With t(8;21)(q22;q22);   Adult Nasal Type Extranodal NK/T-cell Lymphoma;   Aplastic Anemia;   Childhood Acute Lymphoblastic Leukemia in Remission;   Childhood Acute Myeloid Leukemia in Remission;   Childhood Myelodysplastic Syndromes;   Chronic Eosinophilic Leukemia;   Chronic Myelomonocytic Leukemia;   Chronic Neutrophilic Leukemia;   Essential Thrombocythemia;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Juvenile Myelomonocytic Leukemia;   Mastocytosis;   Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable;   Nodal Marginal Zone B-cell Lymphoma;   Polycythemia Vera;   Previously Treated Myelodysplastic Syndromes;   Primary Myelofibrosis;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Myeloid Leukemia;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Myeloid Leukemia;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Mycosis Fungoides/Sezary Syndrome;   Recurrent Small Lymphocytic Lymphoma;   Recurrent/Refractory Childhood Hodgkin Lymphoma;   Refractory Anemia;   Refractory Anemia With Ringed Sideroblasts;   Refractory Hairy Cell Leukemia;   Refractory Multiple Myeloma;   Secondary Myelodysplastic Syndromes;   Splenic Marginal Zone Lymphoma;   T-cell Large Granular Lymphocyte Leukemia;   Waldenström Macroglobulinemia
Interventions: Drug: Fludarabine;   Drug: Thiotepa;   Radiation: Total Body Irradiation (TBI);   Biological: Donor Lymphocyte Infusion (DLI);   Drug: Cyclophosphamide (CY);   Drug: Tacrolimus;   Drug: Mycophenolate mofetil;   Device: Allogeneic hematopoietic stem cell transplantation;   Procedure: Peripheral blood stem cell transplantation (PBSCT)
14 Recruiting The Mechanism of Melanocyte Self-Assembly on Biomaterials and the Functional Analysis
Conditions: Melanocyte;   Vitiligo
Intervention: Behavioral: melanocyte self-assembly and functional analysis
15 Recruiting Clinical and Basic Investigations Into Erdheim Chester Disease
Conditions: Myelofibrosis;   Gaucher Disease;   Pulmonary Fibrosis;   Hermansky-Pudlak Syndrome (HPS);   Cancer
Intervention:
16 Unknown  Oral Ginkgo Biloba and Narrow Band UVB in the Treatment of Vitiligo
Condition: Vitiligo
Intervention: Dietary Supplement: GINGKO BILOBA
17 Unknown  Effect of Fluticasone Proprionate 0.05% on Narrow Band UV-B in Active Vitiligo
Conditions: Patients With Active Non-segmental Vitiligo.;   Evaluation of the Efficacy of UVB and Fluticason Proprionate 0.05%;   Cream Compared to NB-UVB Alone in Patients With Non-segmental Vitiligo
Intervention: Drug: Fluticasone proprionate 0.05% cream
18 Recruiting Study of Factors Regulating Mast Cell Proliferation
Condition: Mastocytosis
Intervention:
19 Unknown  Audiological Disturbances in Vitiligo
Conditions: Vitiligo;   Hearing Loss
Intervention:
20 Recruiting A Multicenter Trial of Non-cultured Epidermal Cellular Grafting Versus Hyaluronic Acid for Repigmenting Stable Leukoderma (Vitiligo and Piebaldism)
Conditions: Vitiligo;   Piebaldism
Interventions: Device: VITICELL;   Device: PLACEBO

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years